Astellas Pharma Inc (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Sales | 11,350,060 | 11,067,000 | 10,698,000 | 11,822,000 | 11,790,790 |
| Cost of Goods | 3,032,093 | 3,210,000 | 3,448,000 | 3,886,000 | N/A |
| Gross Profit | 8,317,964 | 7,857,000 | 7,250,000 | 7,936,000 | 11,790,790 |
| Operating Expenses | 6,628,523 | 6,725,000 | 5,613,000 | 6,332,000 | 0 |
| Operating Income | 1,689,533 | 1,134,000 | 1,637,000 | 1,604,000 | 11,790,790 |
| Interest Expense | 28,010 | 16,000 | 0 | 0 | 0 |
| Other Income | 64,592 | 66,000 | -311,000 | -54,000 | 0 |
| Pre-tax Income | 1,726,115 | 1,184,000 | 1,326,000 | 1,550,000 | 11,790,790 |
| Income Tax | 489,826 | 302,000 | 445,000 | 596,000 | N/A |
| Net Income Continuous | 1,236,290 | 882,000 | 881,000 | 981,004 | 836,154 |
| Net Income | $1,236,290 | $882,000 | $881,000 | $954,000 | $836,154 |
| EPS Basic Total Ops | 0.56 | 0.39 | 0.38 | 0.42 | 0.36 |
| EPS Basic Continuous Ops | 0.56 | 0.39 | 0.38 | 0.42 | 0.36 |
| EPS Diluted Total Ops | 0.56 | 0.39 | 0.38 | 0.42 | 0.36 |
| EPS Diluted Continuous Ops | 0.56 | 0.39 | 0.38 | 0.42 | 0.36 |
| EBITDA(a) | $2,285,347 | $1,756,000 | $2,252,000 | $2,403,000 | $11,790,790 |